MENDLEIN JOHN
SEC CIK 1238362 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FATE | FATE THERAPEUTICS INC | Dir | 311.2K | $698.1K | $1.14M | 6 | 2022-03-10 | 2023-01-19 |
Most active insiders at FATE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Valamehr Bahram | Pres, CEO, Dir | — | $168.1K |
| 2 | TAHL CINDY | See Remarks | — | $154.7K |
| 3 | Adawi Kamal | CFO | — | — |
| 4 | Redmile Group, LLC | Dir, 10% | — | — |
| 5 | EPSTEIN ROBERT S | Dir | — | — |
| 6 | RASTETTER WILLIAM H | Dir | — | — |
MENDLEIN JOHN made no open-market trades at FATE in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-20 | 2023-01-19 | FATE | FATE THERAPEUTICS INC | MENDLEIN JOHN | Dir | M - OptEx | $1.37 | +28.5K | 311.2K | +10% | +$39.0K |
| M | 2023-01-13 | 2023-01-11+ | FATE | FATE THERAPEUTICS INC | MENDLEIN JOHN | Dir | P - Purchase | $5.60 | +124.7K | 246.1K | +103% | +$698.1K |
| D | 2022-06-13 | 2022-06-09 | FATE | FATE THERAPEUTICS INC | MENDLEIN JOHN | Dir | A - Grant | $0.00 | +8,650 | 166.7K | +5% | $0 |
| 2022-06-06 | 2022-06-03 | FATE | FATE THERAPEUTICS INC | MENDLEIN JOHN | Dir | S - Sale | $22.79 | -1,364 | 158.1K | -0.9% | -$31.1K | |
| D | 2022-03-11 | 2022-03-10 | FATE | FATE THERAPEUTICS INC | MENDLEIN JOHN | Dir | M - OptEx | $1.63 | +31.6K | 191.0K | +20% | +$51.4K |
| DM | 2022-03-11 | 2022-03-10 | FATE | FATE THERAPEUTICS INC | MENDLEIN JOHN | Dir | S - Sale+OE | $35.02 | -31.6K | 171.5K | -16% | -$1.11M |
Purchase Sale Sale after option exercise All abbreviations